marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-08-2023
ACADIA Pharmaceuticals Financial Ratios 2011-2024 | ACAD
Annual Financial Ratios ACADIA Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-21.0 | -26.8 | -25.0 | -11.8 | -13.0 | -13.9 | -12.7 | -32.0 | -53.8 | -16.3 | -3.5 |
P/S |
7.3 | 17.1 | 17.4 | 13.0 | 30.1 | 217.9 | 34131.7 | 24660.5 | 1782.4 | 69.1 | 38.6 |
EPS |
-1.1 | -1.8 | -1.6 | -1.9 | -2.4 | -2.3 | -1.6 | -0.9 | -0.4 | -0.4 | -0.4 |
EV (Enterprise Value) |
3.54 B | 7.39 B | 5.78 B | 2.83 B | 3.74 B | 3.66 B | 2 B | 2.91 B | 2.04 B | 305 M | 81.7 M |
EBITDA per Share |
-1.05 | -1.8 | -1.66 | -1.93 | -2.36 | -2.34 | -1.63 | -0.957 | -0.446 | -0.377 | -0.432 |
EV/EBITDA |
-21.1 | -25.5 | -23.4 | -11.3 | -12.7 | -13.3 | -12.1 | -31.1 | -53.1 | -13.5 | -3.2 |
PEG |
1.63 | 2.26 | -1.43 | -0.67 | 15.19 | 0.32 | 0.18 | 0.28 | 3.41 | -1.19 | 0.02 |
P/B |
6.5 | 12.1 | 8.4 | 6.1 | 11.2 | 7.3 | 10.4 | 9.6 | 11.2 | 4.0 | 3.4 |
P/CF |
-28.1 | -52.6 | -38.7 | -17.1 | -17.2 | -17.2 | -16.8 | -44.4 | -63.0 | -15.7 | -4.0 |
ROE % |
-31.04 | -44.91 | -33.65 | -51.18 | -86.32 | -52.35 | -82.32 | -29.88 | -20.84 | -24.53 | -97.44 |
ROA % |
-23.98 | -35.98 | -30.04 | -45.39 | -75.27 | -48.36 | -74.11 | -28.41 | -20.07 | -19.20 | -70.89 |
ROCE % |
-31.51 | -42.35 | -34.81 | -51.48 | -87.16 | -52.61 | -82.31 | -30.11 | -21.03 | -20.35 | -88.07 |
Current Ratio |
4.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | 27.0 | 18.2 | 5.2 |
DSO |
42.4 | 41.5 | 40.8 | 45.3 | 53.9 | 150.4 | 9801.1 | 2932.2 | - | - | - |
DIO |
400.2 | 172.0 | 118.1 | 81.0 | 146.7 | 345.9 | - | - | - | - | - |
DPO |
258.7 | 150.8 | 134.5 | 63.1 | 245.6 | 324.1 | - | - | - | - | - |
Operating Cycle |
442.7 | 213.5 | 158.9 | 126.4 | 200.5 | 496.2 | - | - | - | - | - |
Cash Conversion Cycle |
184.0 | 62.7 | 24.4 | 63.3 | -45.0 | 172.2 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios ACADIA Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.27 | - | - | -0.21 | -0.7 | -0.27 | -0.09 | -0.27 | -0.42 | -0.42 | -0.05 | -0.27 | -0.57 | -0.34 | -0.29 | -0.38 | -0.59 | -0.5 | -0.5 | -0.51 | -0.44 | -0.55 | -0.53 | -0.55 | -0.72 | -0.65 | -0.61 | -0.63 | -0.45 | -0.45 | -0.39 | -0.39 | -0.4 | -0.28 | -0.25 | -0.22 | -0.19 | -0.13 | -0.12 | -0.11 | -0.08 | -0.11 | -0.04 | -0.1 | -0.12 | -0.1 | -0.1 | -0.12 | -0.12 |
EBITDA per Share |
-0.33 | - | - | -202 | -0.7 | - | -0.09 | -266 | -0.41 | - | -0.54 | -0.28 | -0.57 | - | -0.3 | -0.39 | -0.61 | - | -0.48 | -0.51 | -0.44 | - | -0.53 | -0.55 | -0.73 | - | -0.61 | -0.63 | -0.45 | - | -0.38 | -0.39 | -0.4 | - | -0.25 | -0.22 | -0.19 | - | -0.12 | -0.11 | -0.08 | - | -0.04 | -0.1 | -0.12 | - | -0.09 | -0.12 | -0.11 |
ROE % |
-27.14 | -41.06 | -41.21 | -43.76 | -43.70 | -29.71 | -32.39 | -43.34 | -42.30 | -44.91 | -41.85 | -34.35 | -35.49 | -33.65 | -39.73 | -46.70 | -52.05 | -51.18 | -58.05 | -64.54 | -71.45 | -86.32 | -80.95 | -75.31 | -68.95 | -52.35 | -60.09 | -65.75 | -71.71 | -82.32 | -68.57 | -57.10 | -44.33 | -29.88 | -27.33 | -25.19 | -23.23 | -20.84 | -22.23 | -19.19 | -20.58 | -24.53 | -39.21 | -58.11 | -79.79 | -97.44 | -21.73 | -28.06 | -24.97 |
ROA % |
-17.67 | -29.21 | -29.82 | -31.83 | -32.34 | -23.02 | -25.40 | -34.20 | -33.53 | -35.98 | -34.22 | -28.76 | -30.39 | -30.04 | -35.39 | -41.53 | -46.23 | -45.39 | -51.18 | -56.64 | -62.47 | -75.27 | -71.38 | -67.17 | -62.34 | -48.36 | -54.97 | -59.74 | -64.78 | -74.11 | -62.19 | -52.27 | -41.13 | -28.41 | -26.07 | -24.11 | -22.31 | -20.07 | -19.97 | -16.52 | -16.71 | -19.20 | -29.43 | -43.03 | -58.45 | -70.89 | -15.81 | -20.41 | -18.16 |
ROCE % |
-15.48 | -40.89 | -35.85 | -38.54 | -38.54 | -21.92 | -35.62 | -46.62 | -45.90 | -35.00 | -41.49 | -34.29 | -35.44 | -27.20 | -39.95 | -46.21 | -51.40 | -37.53 | -57.10 | -63.91 | -70.84 | -66.29 | -80.26 | -74.65 | -68.24 | -37.52 | -57.02 | -62.56 | -68.44 | -59.53 | -67.60 | -56.17 | -43.44 | -20.89 | -26.82 | -24.69 | -22.70 | -14.35 | -17.18 | -14.08 | -15.44 | -16.55 | -38.35 | -57.32 | -79.12 | -75.07 | -21.80 | -28.18 | -25.09 |
Current Ratio |
2.3 | 3.1 | - | 3.4 | 3.5 | 4.4 | 4.8 | 4.5 | 4.3 | 5.0 | 5.0 | 5.0 | 5.0 | 9.3 | 9.3 | 9.3 | 9.3 | 8.8 | 8.8 | 8.8 | 8.8 | 7.8 | 7.8 | 7.8 | 7.8 | 13.1 | 13.1 | 13.1 | 13.1 | 10.0 | 10.0 | 10.0 | 10.0 | 20.4 | 20.4 | 20.4 | 20.4 | 27.1 | 27.1 | 27.1 | 27.1 | 18.3 | 18.3 | 11.8 | 12.2 | 3.7 | 3.7 | 3.7 | 3.7 |
DSO |
49.3 | - | - | 44.3 | 50.2 | 43.6 | 38.9 | 42.8 | 45.0 | 36.4 | 36.5 | 40.0 | 42.6 | 33.2 | 34.5 | 39.2 | 44.8 | 40.0 | 40.8 | 41.7 | 40.5 | 36.3 | 44.5 | 51.9 | 69.4 | 45.0 | 102.2 | 5553.1 | 67331.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
618.0 | - | - | 440.4 | 422.4 | - | 310.8 | 381.1 | 417.5 | - | 440.6 | 304.8 | 261.2 | - | 239.5 | 195.6 | 161.0 | - | 96.7 | 104.3 | 197.5 | - | 224.3 | 215.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
825.7 | - | - | 387.0 | 272.9 | - | 207.7 | 323.6 | 362.1 | - | 386.5 | 267.3 | 256.2 | - | 272.8 | 222.8 | 160.7 | - | 75.3 | 81.1 | 253.3 | - | 375.5 | 360.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
667.3 | - | - | 484.7 | 472.6 | 43.6 | 349.6 | 423.9 | 462.5 | 36.4 | 477.1 | 344.7 | 303.8 | 33.2 | 274.0 | 234.8 | 205.9 | 40.0 | 137.6 | 146.0 | 238.0 | 36.3 | 268.8 | 267.2 | 69.4 | 45.0 | 102.2 | 5553.1 | 67331.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-158.4 | - | - | 97.7 | 199.7 | 43.6 | 142.0 | 100.3 | 100.3 | 36.4 | 90.6 | 77.4 | 47.6 | 33.2 | 1.2 | 12.1 | 45.2 | 40.0 | 62.3 | 64.8 | -15.3 | 36.3 | -106.7 | -93.2 | 69.4 | 45.0 | 102.2 | 5553.1 | 67331.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency